Mirae Asset Sharekhan

DOWNLOAD SHAREKHAN APP

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Adline Chem Lab Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Adline Chem Lab Ltd

Thu 21/08/2025,16:1:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 17.90

Previous Close

₹ 17.10

Volume

300

Mkt Cap ( Rs. Cr)

₹10.50

High

₹ 17.95

Low

₹ 17.90

52 Week High

₹ 26.01

52 Week Low

₹ 9.40

Book Value Per Share

₹ -2.55

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Adline Chem Lab Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Adline Chem Lab Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Adline Chem Lab - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

14 Aug 2025, 4:26PM intimation regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30of SEBI (LODR) Regulations, 2015.
Adline Chem Lab - Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30, 2025

12 Aug 2025, 5:46PM Unaudited Standalone Financial Results of the Company for the Quarter Ended June 30, 2025
Adline Chem Lab - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting For Unaudited Standalone Finan

12 Aug 2025, 5:38PM Adline Chem Lab Limited has informed BSE that the Board of Directors of the Company has considered and approved Unaudited Standalone Financial Results
Adline Chem Lab - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone Financial Results For T

5 Aug 2025, 5:36PM Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and
Adline Chem Lab - Scrutinizer\S Report

23 Jul 2025, 6:02PM Voting Results under Regulation 44 of SEBI (LODR) Regulation, 2015 of the business transacted at the AGM held on 22nd July, 2025 at 02.00 P.M.
Adline Chem Lab - Shareholder Meeting / Postal Ballot-Outcome of AGM

22 Jul 2025, 5:38PM Outcome and Summary of the Proceedings of Annual General Meeting held on Tuesday, 22nd July, 2025.
Adline Chem Lab has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

19 Jul 2025, 7:00AM As of June 2025, 25.85% is owned by Indian Promoters and 74.15% by Public. <p align=justify> Top Promoter holding highest number of shares of Adline C
Adline Chem Lab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

15 Jul 2025, 5:54PM Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2025, is enclosed herewith.
Adline Chem Lab - AGM OF THE COMPANY SCHEDULED TO BE HELD ON TUESDAY, 22ND JULY, 2025 AT 02:00 P.M.

27 Jun 2025, 3:43PM Notice is hereby given that the AGM of the Company is schedule to be held on Tuesday, 22nd July, 2025.
Adline Chem Lab - Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Require

27 Jun 2025, 3:12PM Intimation of Record Date
Adline Chem Lab - Rescheduled Of Annual General Meeting

20 Jun 2025, 6:28PM Due to some unavoidable circumstances the Board of Directors of the Company rescheduled the Annual General Meeting from 11th July 2025 to 22nd July o
Adline Chem Lab - Appointment Of Secretarial Auditor.

13 Jun 2025, 6:28PM The Board at its meeting held today 13.06.2025 considered and approved the appointment of M/s. Ishit Vyas & Co., Practicing Company Secretary, Ahmedab
Adline Chem Lab - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

13 Jun 2025, 6:21PM The Board at its meeting held today 13.06.2025 has considered and approved alteration of the Main object of the Memorandum of Association by inserting
Adline Chem Lab - Announcement under Regulation 30 (LODR)-Change in Directorate

13 Jun 2025, 6:14PM The Board at its meeting held today 13.06.2025 and on the recommendation of Nomination and remuneration committee, has considered and approved the app
Adline Chem Lab - Appointment Of CFO

13 Jun 2025, 6:09PM The Board at its meeting held today 13.06.2025 appointed Mr. Hardik Vaghasiya as the Chief Financial Officer of the Company due to resignation of exis
Adline Chem Lab - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

13 Jun 2025, 6:06PM Considered and approved Shifting of Registered Office of the Company within local limits of the City.
Adline Chem Lab - Appointment of Company Secretary and Compliance Officer

13 Jun 2025, 6:03PM Appointment of Ms. Akshita Khandelwal, Qualified Company Secretary (M.No.: A63342), as Company Secretary and Compliance officer of the Company w.e.f.
Adline Chem Lab - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

13 Jun 2025, 5:59PM \r\nThe Board has at its meeting held today 13.06.2025 considered and took the note of the resignation of Mr. Kuldip Parekh from the post of Chief Fin
Adline Chem Lab - Board Meeting Outcome for Outcome Of Board Meeting

13 Jun 2025, 5:54PM Outcome of Board Meeting enclosed herewith

Key fundamentals

Evaluate the intrinsic value of Adline Chem Lab Ltd stock

Name	March-25	March-24	March-23	March-22	March-21
Assets	-0.0055	-0.2312	-0.2343	3.9651	4.432
Liabilities	-0.0055	-0.2312	-0.2343	3.9651	4.432
Equity	5.85	5.85	5.85	5.85	5.85
Gross Profit	-0.2938	-0.1771	-0.7966	-0.2962	-0.2305
Net Profit	-0.1322	-0.1465	-4.234	0.7178	-1.2833
Cash From Operating Activities	-0.2261	-0.0196	0.0138	0.2113	-0.2941
NPM(%)	0	0	0	97.44	-20.28
Revenue	0	0	0	0.7366	6.3281
Expenses	0.2938	0.1771	0.7966	1.0328	6.5587
ROE(%)	8.85	9.81	283.53	-48.06	85.94

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2024	2025	Equity Share	6.00	5.85	5850000.00	10	5.85
2023	2024	Equity Share	6.00	5.85	5850000.00	10	5.85
2022	2023	Equity Share	6.00	5.85	5850000.00	10	5.85
2021	2022	Equity Share	6.00	5.85	5850000.00	10	5.85
2020	2021	Equity Share	6.00	5.85	5850000.00	10	5.85
2019	2020	Equity Share	6.00	5.85	5850000.00	10	5.85
2018	2019	Equity Share	6.00	5.85	5850000.00	10	5.85
2017	2018	Equity Share	6.00	5.85	5850000.00	10	5.85
2016	2017	Equity Share	6.00	5.85	5850000.00	10	5.85
2015	2016	Equity Share	6.00	5.85	5850000.00	10	5.85
2014	2015	Equity Share	6.00	5.85	5850000.00	10	5.85
2013	2014	Equity Share	6.00	5.85	5850000.00	10	5.85
2012	2013	Equity Share	6.00	5.85	5850000.00	10	5.85
2011	2012	Equity Share	6.00	5.85	5850000.00	10	5.85
2010	2011	Equity Share	6.00	5.85	5850000.00	10	5.85
2009	2010	Equity Share	6.00	5.85	5850000.00	10	5.85
2008	2009	Equity Share	6.00	5.85	5850000.00	10	5.85
2007	2008	Equity Share	6.00	5.85	5850000.00	10	5.85
2006	2007	Equity Share	6.00	5.85	5850000.00	10	5.85
2005	2006	Equity Share	6.00	5.85	5850000.00	10	5.85
2004	2005	Equity Share	6.00	5.85	5850000.00	10	5.85
1993	1996	Equity Share	6.00	5.85	5850000.00	10	5.85
1992	1993	Equity Share	6.00	5.85	5850000.00	10	5.85
1991	1992	Equity Share	6.00	0.05	50000.00	10	0.05

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Adline Chem Lab Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	802.00	0.50	72.66	10.24	301.39	0.62
Lotus Eye Hospital and Institute Ltd	116.91	6.94	376.90	37.33	3.55	0.00
Bharat Immunological and Biologicals Corporation Ltd	21.30	-1.07	0.00	77.51	-39.50	0.00
Astec Lifesciences Ltd	879.30	2.33	0.00	35.20	-604.77	0.00

Company Info

Karon Laboratories Ltd is an existing profit making company incorporated on 6.7.88 as a Private Ltd company. It became a public ltd company on 08.01.89. the company is engaged in formulation of pharmaceuticals. The company is promoted by Kamalesh Jagdish Laskari and his family associates. 2022 -Company name has changed to Adline Chem Lab Ltd. from Kamron Laboratories Ltd.

Karon Laboratories Ltd is an existing profit making company incorporated on 6.7.88 as a Private Ltd company. It became a public ltd company on 08.01.89. the company is engaged in formulation of pharmaceuticals. The company is promoted by Kamalesh Jagdish Laskari and his family associates. 2022 -Company name has changed to Adline Chem Lab Ltd. from Kamron Laboratories Ltd.

Read More

Parent Organisation

Adline Chem Lab Ltd.

Founded

06/07/1988

Managing Director

Mr.Sarang Bharatbhai Pathak

NSE Symbol

FAQ

The current price of Adline Chem Lab Ltd is ₹ 17.95.

The 52-week high for Adline Chem Lab Ltd is

The market capitalization of Adline Chem Lab Ltd is currently ₹ 10.50. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Adline Chem Lab Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Adline Chem Lab Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Adline Chem Lab Ltd shares.

The CEO of Adline Chem Lab Ltd is Mr.Sarang Bharatbhai Pathak, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT